Colony NorthStar Inc (CLNS) Given Consensus Recommendation of “Buy” by Analysts
Shares of Colony NorthStar Inc (NYSE:CLNS) have received an average recommendation of “Buy” from the seven brokerages that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $16.05.
Several equities research analysts have recently weighed in on the stock. B. Riley reaffirmed a “buy” rating and issued a $15.00 target price on shares of Colony NorthStar in a report on Friday, November 10th. FBR & Co reaffirmed a “buy” rating and issued a $15.00 target price on shares of Colony NorthStar in a report on Tuesday, October 3rd. ValuEngine raised shares of Colony NorthStar from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Zacks Investment Research raised shares of Colony NorthStar from a “strong sell” rating to a “hold” rating in a report on Monday, October 23rd. Finally, JMP Securities raised shares of Colony NorthStar from a “market perform” rating to an “outperform” rating and set a $13.00 target price on the stock in a report on Friday, January 5th.
In related news, insider David T. Hamamoto sold 2,225,909 shares of the company’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $12.09, for a total transaction of $26,911,239.81. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Vice Chairman David T. Hamamoto sold 805,174 shares of the company’s stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $12.15, for a total transaction of $9,782,864.10. The disclosure for this sale can be found here. In the last quarter, insiders have sold 3,493,363 shares of company stock worth $42,260,703. 7.99% of the stock is owned by corporate insiders.
Shares of Colony NorthStar (NYSE CLNS) opened at $10.18 on Tuesday. The stock has a market cap of $5,539.15, a price-to-earnings ratio of 42.25 and a beta of 1.49. The company has a quick ratio of 4.64, a current ratio of 4.64 and a debt-to-equity ratio of 0.95. Colony NorthStar has a fifty-two week low of $10.10 and a fifty-two week high of $14.74.
Colony NorthStar (NYSE:CLNS) last posted its earnings results on Thursday, November 9th. The real estate investment trust reported $0.33 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.33. Colony NorthStar had a net margin of 5.83% and a return on equity of 1.88%. The business had revenue of $788.90 million for the quarter, compared to analyst estimates of $695.50 million. The company’s revenue was up 271.9% on a year-over-year basis. equities research analysts forecast that Colony NorthStar will post 1.04 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Monday, January 15th. Investors of record on Friday, December 29th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $1.08 annualized dividend and a yield of 10.61%.
About Colony NorthStar
Colony NorthStar, Inc is a diversified equity real estate investment trust (REIT). The Company combines a portfolio of real assets across the world, which are managed with a global real estate investment manager. The Company has property holdings in the healthcare, industrial and hospitality sectors, opportunistic equity and debt investments, and an embedded institutional and retail investment management business.
Receive News & Ratings for Colony NorthStar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colony NorthStar and related companies with MarketBeat.com's FREE daily email newsletter.